111E3139E3148
Ozempic and Mounjaro are brand names used for those with diabetes
Currently, the FDA has officially approved a higher-dose formulation of semaglutide called Wegovy specifically for chronic weight management in adults who are overweight or obese, even if they do not have diabetes
For example, in a study where obese volunteers had unlimited access ( ad libitum ) to three meals (lunch, dinner and snacks), it was observed that treatment with semaglutide (1 mg/wk) caused a 24% decrease in energy intake during the day, leading to a reduction in body weight of approximately 5 kg after 12 weeks of treatment
It is important to emphasise that individuals should not attempt to obtain retatrutide outside of authorised clinical trial settings
It feels like a cruel irony: the very tool meant to quiet the food noise can, in some cases, lead to a breakthrough binge